Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer

Robert C Stein, Andrea Marshall, Andreas Makris, Luke Hughes-Davies, Iain R MacPherson, Carmel Conefrey, Leila Rooshenas, Sarah E Pinder, Abeer M Shaaban, Bjørn Naume, David A Cameron, Daniel W Rea, Helena M Earl, Christopher J Poole, Peter S Hall, Georgina Dotchin, Stuart A McIntosh, Victoria Harmer, Adrienne Morgan, Bethany ShinkinsNigel Stallard, Christopher McCabe, Jenny L Donovan, John MS Bartlett, Janet A Dunn

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Article numberOT3-17-01
JournalCancer Res
Volume80
Issue number4 Supplement
DOIs
Publication statusPublished - 14 Feb 2020

Cite this